
About


Federal Circuit: Patent Must Claim Active Ingredient for Orange Book Listing

USPTO Finalizes Fee Increases for 2025: What to Expect in the New Year and What to do Now

The Corporate Transparency Act: What you Need to Know to Comply with the New Requirements

Brave New World: UPC Central Division’s First Opinion is a Revocation of Antibody Claims as Lacking Inventive Step

USPTO Fees Are Rising Drastically in 2025: What to Do Now to Save Thousands of Dollars

Client Spotlight: BASE Air Management

Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease

Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
